Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the ‘real world’ and the need for risk stratification
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 16 (7) , 461-464
- https://doi.org/10.1097/01.mbc.0000184739.35347.13
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 1Published by Elsevier ,2004
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996European Heart Journal, 2001
- Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectivenessBMJ, 2000
- Quality of Anticoagulation Management Among Patients With Atrial FibrillationArchives of internal medicine (1960), 2000
- Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAnnals of Internal Medicine, 1999
- Antithrombotic Therapy To Prevent Stroke in Patients with Atrial FibrillationAnnals of Internal Medicine, 1999
- Underutilization of Warfarin in Older Persons with Chronic Nonvalvular Atrial Fibrillation at High Risk for Developing StrokeJournal of the American Geriatrics Society, 1998
- Prevalence of atrial fibrillation and eligibility for anticoagulants in the communityThe Lancet, 1998
- Recent National Patterns of Warfarin Use in Atrial FibrillationCirculation, 1998